Aura Biosciences CEO Elisabeth de los Pinos sells $122,381 worth of stock By Investing.com
Elisabeth de los Pinos, President and CEO of Aura Bioscience (NASDAQ:), recently sold 15,955 shares of the company’s stock, valued at $122,381. The biotech company, currently valued at $388 million, maintains a financial health score of “FAIR” according to InvestingPro’s analysis. Shares traded at a weighted average of $7.67, with transactions ranging between $7.67 and $7.72 per share. After the sale, de los Pinos owns 304,692 shares directly, with another 131,412 shares held indirectly through the Elisabeth de los Pinos Revocable Trust. The sale was intended to cover withholding tax obligations related to the grant of restricted stock units and was non-discretionary. While the company faces profitability challenges, analysts maintain optimistic price targets of $20 to $23 per share. InvestingPro subscribers can access additional information about AURA’s financial health and growth, including 6 key ProTips.
This article was created with the support of AI and reviewed by an editor. For more information see our T&C.
